Joo Yong Lee_SCIENTIFIC POSTER 2015

Purpose:

To report two cases of choroidal neovascularization (CNV) secondary to chronic central serous chorioretinopathy (CSC) treated with anti-vascular endothelial growth factor (VEGF).

Methods:

Two eyes with CNV associated with chronic CSC were treated with intravitreal injection of ranibizumab (0.5 mg/0.05cc) or bevacizumab (1.25mg/0.05cc) and were evaluated for best corrected visual acuity (BCVA), fluorescein angiography, indocyanine angiography and optical coherent tomography (OCT) before treatment and monitored with BCVA and OCT at 1, 3, 6, and 12 months after treatment.

Results:

These two patients showed improvement in visual acuity and resolved neurosensory detachment following 4 to 6 intravitreal anti-VEGF injections. During the follow up period, there was no recurrence of subretinal fluid or hemorrhage.

Conclusions:

Intravitreal anti-VEGF appeared to be an effective treatment for CNV related to chronic CSC. Although treatment results are promising, further investigations would be warranted to evaluate the long-term efficacy in the treatment of these relatively rare conditions.

Contact Details:

Email: ophthalmo@amc.seoul.kr
Cell Phone: +8201028963560